Celsius Q1 Earnings Beat, But Q2 Outlook Remains Blank

Forward-Looking Analysis

The provided source material contains no specific financial projections, revenue forecasts, or EPS estimates for Celsius Holdings (CELH) for the 2026Q2 period. Consequently, it is impossible to extract projected revenue, net profit, or earnings per share data from the provided text. The available news summaries do not contain any analyst predictions, bank recommendations, or price targets specifically for Celsius Holdings. The content primarily discusses unrelated entities such as Carnival Corporation (CCL) and KLA Corporation (KLAC), along with general macroeconomic indicators like the US Jobs Report. Without explicit data points regarding Celsius Holdings' forward-looking financial expectations in the source material, no forward-looking analysis can be synthesized without violating the strict requirement to avoid speculation and rely solely on provided content. Therefore, the earnings expectations section cannot be populated with factual data from the sources provided.

Historical Performance Review

Celsius Holdings delivered strong 2026Q1 results, generating $782.62 million in revenue and $378.07 million in gross profit. Net income reached $110.10 million, supporting an EPS of $0.33. These figures demonstrate robust top-line growth and healthy profitability margins, establishing a solid operational baseline heading into the second quarter of 2026.

Additional News

The provided source material does not contain any recent news, announcements, or updates specific to Celsius Holdings. There are no reports regarding company movements, new product launches, mergers and acquisitions, or executive activities for CELH in the provided text. The available content focuses exclusively on other market entities and general economic data, leaving a gap in qualitative information regarding Celsius Holdings' recent operational developments or strategic initiatives.

Summary & Outlook

Based on the limited available data, Celsius Holdings demonstrated strong financial health in Q1 2026 with $782.62M revenue and $0.33 EPS. However, the complete absence of Q2 projections, analyst targets, or recent corporate news in the provided sources prevents a definitive assessment of growth catalysts or risks. Without forward-looking data, maintaining a neutral stance is prudent, as bullish or bearish conclusions cannot be substantiated by the current information set. Investors must await official earnings releases or updated analyst reports to gauge future prospects accurately.